Hofmeister Robert 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 11, 2020
Insider Transaction Report
Form 4
Hofmeister Robert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-12-10+76,000→ 76,000 totalExercise: $31.83Exp: 2030-12-09→ Common Stock (76,000 underlying)
Holdings
- 38,850
Common Stock
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.